semaglutide onset of action Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), a major breakthrough for the treatment obesity POTD: Wegovy and Ozempic —

Amato A, Cinci L, Rotondo A, Serio R, Faussone-Pellegrini MS, Vannucchi MG, et al

Originally developed to manage type 2 diabetes, GLP-1 receptor agonists have gained popularity for their appetite-suppressing and weight-loss effects, with the study finding that most prescriptions are now issued to women without diabetes

Common Misconceptions There is a lot of informationand misinformationonline regarding these two supplements

Reducing inflammation Inflammatory conditions like IBS or leaky gut can slow down bowel movements

Much like any new medication application, FDA approval will be needed before widespread adoption can safely occur